Biomax Biotechnics Private Limited

Biomax Biotechnics Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24100CH2009PTC031718 Incorporated 13 August 2009 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹38.1 Cr
▲ 9% YoY
Net profit · FY 2025
₹27.98 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹2.75 Cr
EBITDA margin 7.2%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹14.49 Cr
Satisfied ₹11.37 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
68
Provident fund records

About Biomax Biotechnics Private Limited

Data last updated:

Biomax Biotechnics Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2009PTC031718. Its GSTIN is 06AADCB8274H1ZK (Haryana). The company holds 6 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Kamaljit Singh (Managing Director) and Shobhana.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 1013 Second Floor H – 1 Motor Market Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2025, the company reported a revenue of ₹38.1 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹27.98 Lakh (net margin 0.7%) and EBITDA of ₹2.75 Cr (EBITDA margin 7.2%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.

The company has about 68 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹14.49 Cr and satisfied charges of ₹11.37 Cr on record. Court records list 41 cases involving the company, including 23 filed by the company and 18 filed against it; 20 cases are pending.

Biomax Biotechnics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0001610). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biomaxbiotechnics.in.

Company details

CIN U24100CH2009PTC031718
Registration Number 031718
Incorporation Date 13 August 2009
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0001610

Recognitions & Rankings of Biomax Biotechnics

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-CH-01-0001610

Contact details

Biomax Biotechnics Private Limited's registered office is in Chandigarh, Chandigarh. Its website is biomaxbiotechnics.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Scf 1013 Second Floor H – 1 Motor Market Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Biomax Biotechnics Private Limited, buy the company report.

Comprehensive company report
Biomax Biotechnics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activities of Biomax Biotechnics are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Biomax Biotechnics Private Limited, buy the company report.

Financials of Biomax Biotechnics Private Limited

FY 2025 filings available

Biomax Biotechnics Private Limited reported revenue of ₹38.1 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹38.1 Cr ▲ 9%
Net profit · FY 2025
₹27.98 Lakh margin 0.7%
EBITDA · FY 2025
₹2.75 Cr margin 7.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 8%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 25%
5 years · compounded
▼ 2%

Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.75 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27.98 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.2%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biomax Biotechnics Private Limited, buy the company report.

Board of directors of Biomax Biotechnics Private Limited

Biomax Biotechnics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
ShobhanaDirector13 Dec 201213 Years 10 MonthsCurrent
Kamaljit SinghManaging Director13 Aug 200917 Years 2 MonthsCurrent

Peer comparison

Biomax Biotechnics Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medicamen Organics Limited.₹38.28 Cr (FY 2025)51.0%New Delhi, Delhi, India
Diamond Drugs Private Limited₹38.26 Cr (FY 2024)2.0%Kolkata, West Bengal, India
Klar Sehen Pvt Ltd₹38.16 Cr (FY 2016)18.0%Bidar, Karnataka, India
Tulip Lab Private Limited₹38.12 Cr (FY 2023)-78.0%Mumbai, Maharashtra, India
Biomax Biotechnics Private Limitedthis company₹38.1 Cr (FY 2025)₹27.98 Lakh0.7%9.0%68Chandigarh, India
Zivira Labs Private Limited₹38.07 Cr (FY 2025)22.0%Mumbai, Maharashtra, India
VVR Organics Private Limited₹38.01 Cr (FY 2024)9.0%Hyderabad, Telangana, India
Purogene Labs Private Limited₹37.79 Cr (FY 2025)36.0%Hyderabad, Telangana, India

To see the full peer comparison of Biomax Biotechnics Private Limited, buy the company report.

Auditor

Biomax Biotechnics Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
VIKAS SANJIV & ASSOCIATESFY 2024018361N

Shareholding

The shareholding of Biomax Biotechnics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biomax Biotechnics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹14.49 Cr
Satisfied charges
₹11.37 Cr
Breakdown by lending institutions
Canara Bank₹14.49 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Sep 2023100806296Canara Bank₹10.79 CrOpen
08 Dec 2022100659841Canara Bank₹3.7 CrOpen
03 Mar 2020100342820Axis Bank Limited₹36.76 LakhSatisfied
27 Dec 2017100148665Idbi Bank Limited₹8.91 CrSatisfied
27 Nov 201510626421Icici Bank Limited₹36 LakhSatisfied

To see the full charge records of Biomax Biotechnics Private Limited, buy the company report.

Total charge records: 8 View all charges

Credit ratings & regulatory alerts

Biomax Biotechnics Private Limited was last rated by Crisil on 18 Aug 2018.

Rating agencyRated onRating
Crisil18 Aug 2018

To see the full credit ratings and regulatory alerts of Biomax Biotechnics Private Limited, buy the company report.

MSME payment delays

Biomax Biotechnics Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 57 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
an individual supplier
Aspen Lifesciences
Ultra Drugs Private Limited
Asterisk Healthcare
Roma Pharma Private Limited

To see the full MSME payment records of Biomax Biotechnics Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Biomax Biotechnics has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Baxton Pharmacia Private LimitedU24232CH2012PTC033455

To see the full group structure of Biomax Biotechnics Private Limited, buy the company report.

Employees & EPFO

Biomax Biotechnics Private Limited has a workforce of 68 employees on its EPFO records as of Aug 31, 2024, across 1 active EPFO establishment.

Employee count
68
Active EPFO establishments
1
Employee growth
-16.05%

GST

Biomax Biotechnics has 6 GST registrations: 4 active and 2 cancelled or inactive.

Total GSTINs
6
Active
4
Cancelled / inactive
2
GSTINStateStatusRegistered on
06AADCB8274H1ZKHaryanaActive04 Jul 2017
06AADCB8274H2ZJHaryanaActive27 Dec 2017
06AADCB8274H3ZIHaryanaActive24 Feb 2022
29AADCB8274H1ZCKarnatakaActive18 Apr 2024

To see the full GST registrations and return filing status of Biomax Biotechnics Private Limited, buy the company report.

Recent activity

Biomax Biotechnics Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Kamaljit Singh ceased to be Director on 01 Sep 2015.

AGM
Biomax Biotechnics Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Biomax Biotechnics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 27 Dec 2017 via Charge ID 100148665 with Idbi Bank Limited was fully satisfied on 25 Oct 2023.
Charges
A charge with Canara Bank amounted to Rs. 1,079.41 Lakh with Charge ID 100806296 was registered on 14 Sep 2023.
Charges
A charge with Idbi Bank Limited of Rs. 891.05 Lakh registered on 27 Dec 2017 with Charge ID 100148665 was modified on 21 Mar 2023.
Charges
A charge registered on 19 Feb 2013 via Charge ID 10416852 with Kotak Mahindra Bank Limited was fully satisfied on 27 Dec 2022.
Charges
A charge with Canara Bank amounted to Rs. 370.00 Lakh with Charge ID 100659841 was registered on 08 Dec 2022.
Charges
A charge registered on 03 Mar 2020 via Charge ID 100342820 with Axis Bank Limited was fully satisfied on 06 Nov 2020.
Charges
A charge registered on 27 Nov 2015 via Charge ID 10626421 with Icici Bank Limited was fully satisfied on 29 May 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.76 Lakh with Charge ID 100342820 was registered on 03 Mar 2020.
Charges
A charge registered on 26 Sep 2011 via Charge ID 10308972 with Kotak Mahindra Bank Limited was fully satisfied on 01 Feb 2019.
Charges
A charge with Idbi Bank Limited amounted to Rs. 891.05 Lakh with Charge ID 100148665 was registered on 27 Dec 2017.

12 earlier events are in the company report.

Frequently asked questions

Biomax Biotechnics is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2009 (17+ years old) and is registered under CIN U24100CH2009PTC031718.

Biomax Biotechnics has 2 current directors:

The latest financial statements of Biomax Biotechnics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Biomax Biotechnics is 06AADCB8274H1ZK, registered in Haryana. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 06AADCB8274H2ZJ (Haryana), 06AADCB8274H3ZI (Haryana), 29AADCB8274H1ZC (Karnataka).

The CIN (Corporate Identification Number) of Biomax Biotechnics is U24100CH2009PTC031718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biomax Biotechnics has 41 court cases on record: 23 filed by the company and 18 filed against it. 20 are pending.

Biomax Biotechnics was incorporated on 13 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Biomax Biotechnics by revenue are Medicamen Organics Limited, Diamond Drugs Private Limited, Klar Sehen Pvt Ltd, Tulip Lab Private Limited, Zivira Labs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kamaljit Singh ceased to be Director on 01 Sep 2015. Shobhana ceased to be Additional Director on 28 Sep 2013. Jagjit Singh ceased to be Director on 14 Dec 2012. Biomax Biotechnics has 6 board changes on record in total.

Yes, Biomax Biotechnics is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0001610).

Biomax Biotechnics has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 57 overdue payments to 9 micro and small suppliers. The latest return was filed on 08 Jun 2019.

Biomax Biotechnics can be reached through the website biomaxbiotechnics.in. Its registered office is in Chandigarh, India.